Filing Details

Accession Number:
0001209191-21-063225
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-05 17:19:20
Reporting Period:
2021-09-01
Accepted Time:
2021-11-05 17:19:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-01 15 $2.69 13,688 No 4 P Direct
Common Stock Acquisiton 2021-10-04 15 $2.87 13,703 No 4 P Direct
Common Stock Acquisiton 2021-10-05 15 $2.82 13,718 No 4 P Direct
Common Stock Acquisiton 2021-10-06 15 $2.76 13,733 No 4 P Direct
Common Stock Acquisiton 2021-10-07 15 $2.76 13,748 No 4 P Direct
Common Stock Acquisiton 2021-10-08 15 $2.84 13,763 No 4 P Direct
Common Stock Acquisiton 2021-10-11 15 $2.73 13,778 No 4 P Direct
Common Stock Acquisiton 2021-10-12 15 $2.71 13,793 No 4 P Direct
Common Stock Acquisiton 2021-10-13 15 $2.71 13,808 No 4 P Direct
Common Stock Acquisiton 2021-10-14 15 $2.81 13,823 No 4 P Direct
Common Stock Acquisiton 2021-10-15 15 $2.76 13,838 No 4 P Direct
Common Stock Acquisiton 2021-10-18 15 $2.75 13,853 No 4 P Direct
Common Stock Acquisiton 2021-10-19 15 $2.76 13,868 No 4 P Direct
Common Stock Acquisiton 2021-10-20 15 $2.63 13,883 No 4 P Direct
Common Stock Acquisiton 2021-10-21 15 $2.65 13,898 No 4 P Direct
Common Stock Acquisiton 2021-10-22 15 $2.66 13,913 No 4 P Direct
Common Stock Acquisiton 2021-10-25 15 $2.64 13,928 No 4 P Direct
Common Stock Acquisiton 2021-10-26 15 $2.64 13,943 No 4 P Direct
Common Stock Acquisiton 2021-10-27 15 $2.61 13,958 No 4 P Direct
Common Stock Acquisiton 2021-10-28 15 $2.61 13,975 No 4 P Direct
Common Stock Acquisiton 2021-10-29 15 $2.72 13,988 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.